Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Sci Rep. 2018 Dec 13;8(1):17826. doi: 10.1038/s41598-018-36255-w.
The clinical significance of a single Mycobacterium kansasii (MK) isolation in multiple sputum samples remains unknown. We conducted this study to evaluate the outcome and predictors of developing MK-pulmonary disease (PD) within 1 year among these patients. Patients with a single MK isolation from ≥3 sputum samples collected within 3 months and ≥2 follow-up sputum samples and chest radiography in the subsequent 9 months between 2008 and 2016 were included. The primary outcome was development of MK-PD within 1 year, with its predictors explored using multivariate logistic regression analysis. A total of 83 cases of a single MK isolation were identified. The mean age was 68.9 ± 17.9, with a male/female ratio of 1.96. Within 1 year, 16 (19%) cases progressed to MK-PD; risk factors included high acid-fast smear (AFS) grade (≥3), elementary occupation workers, and initial radiographic score >6, whereas coexistence with other nontuberculous mycobacterium species was protective. Among patients who developed MK-PD, all experienced radiographic progression, and 44% died within 1 year. Although a single MK isolation does not fulfil the diagnostic criteria of MK-PD, this disease may develop if having above-mentioned risk factors. Early anti-MK treatment should be considered for high-risk patients.
单一堪萨斯分枝杆菌(MK)在多次痰标本中的分离的临床意义尚不清楚。我们进行了这项研究,以评估这些患者在 1 年内发展为 MK-肺部疾病(PD)的结局和预测因素。纳入标准为 2008 年至 2016 年期间,至少有 3 次在 3 个月内收集且至少有 2 次随访的痰标本和随后 9 个月的胸部影像学检查,至少有 1 次从≥3 次痰标本中分离出单一 MK。主要结局是在 1 年内发展为 MK-PD,并使用多变量逻辑回归分析探讨其预测因素。共确定了 83 例单一 MK 分离病例。平均年龄为 68.9±17.9 岁,男女比例为 1.96。在 1 年内,有 16 例(19%)发展为 MK-PD;危险因素包括高抗酸染色(AFS)分级(≥3)、体力劳动者和初始放射评分>6,而与其他非结核分枝杆菌共存则具有保护作用。在发生 MK-PD 的患者中,所有患者均出现放射学进展,44%在 1 年内死亡。尽管单一 MK 分离不符合 MK-PD 的诊断标准,但如果存在上述危险因素,可能会发展为该病。应考虑对高危患者进行早期抗-MK 治疗。